A cross-sectional analysis of more than 414,000 U.S. participants revealed 5% carried a pathogenic or likely pathogenic germline variant in a cancer susceptibility gene—higher than expected from prior estimates—underscoring the need to reconsider broader population screening as tests become cheaper. | Iduman, JAMA 2025
